How to Get Insurance to Cover Weight Loss Medication


Key Takeaways
blueCheck icon

Getting insurance to cover weight loss medication requires prior authorization and documented medical necessity from your doctor.

blueCheck icon

A BMI of 30 or higher or 27 with a qualifying comorbidity, is the standard eligibility threshold most plans apply.

blueCheck icon

GLP-1 drugs like Wegovy and Zepbound cost over $1,000 per month without coverage approval.

blueCheck icon

A formal internal appeal reverses a significant share of health insurance denials across drug categories, according to CMS internal appeals data.

Can Health Insurance Cover Weight Loss Medication?

Most employer-sponsored and Marketplace plans cover FDA-approved weight loss drugs, but only under specific medical necessity criteria and after prior authorization approval. The drugs most commonly covered include Wegovy, Zepbound and Saxenda. Ozempic is covered only when prescribed for type 2 diabetes, not weight loss alone. Coverage terms vary across the health insurance companies, so confirm your specific plan's terms before starting the process.

Weight loss drug coverage differs from standard prescription coverage in one key way: most formularies place GLP-1 drugs in Tier 3 or Tier 4, so the copay or coinsurance is substantial even with coverage approval. Medicaid coverage for weight loss drugs varies by state. Medicare Part D was barred from covering weight loss drugs until the Treat and Reduce Obesity Act provisions take effect. Understanding these distinctions prepares you for the steps that follow.

  1. 1
    Confirm Your Plan's Formulary and Prior Authorization Requirements

    Log into your insurer's member portal or call the number on your insurance card to check whether your prescribed drug is on the plan formulary. Ask whether prior authorization is required and what tier the drug is assigned to. Aetna, UnitedHealthcare and Cigna each publish formulary search tools online. Tier placement sets your out-of-pocket cost even after an approval comes through.

  2. 2
    Schedule a Medical Necessity Visit With Your Doctor

    Before submitting a prior authorization request, your doctor must document that you meet the plan's clinical eligibility criteria. Standard thresholds are a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity such as type 2 diabetes, hypertension or sleep apnea.

    Ask your doctor to document all qualifying conditions and any prior weight loss interventions because  insurers require evidence of lifestyle modification efforts before approving coverage.

  3. 3
    Have Your Doctor Submit the Prior Authorization Request

    The prior authorization request goes from your doctor's office directly to the insurer on the plan's required form. It must include diagnosis codes, the specific drug and dosage, documented BMI and comorbidities and a letter of medical necessity. Under state and federal rules including CMS requirements for Marketplace plans, insurers must respond to standard prior authorization requests within three to five business days, though timelines vary by state.

  4. 4
    Track Your Authorization Status and Respond Promptly

    After submission, check the insurer portal or contact your doctor's office every 48 hours. Insurers frequently request additional information or peer-to-peer reviews, and a delayed response can reset the review clock. A peer-to-peer review means your doctor speaks directly with the insurer's medical reviewer (this should improve approval rates).

  5. 5
    Review Your Approval Notice and Confirm Cost-Sharing Terms

    The approval notice specifies which drug and dosage are approved, the approval period (renewal is required every three to 12 months depending on the insurer) and your cost-sharing terms. Confirm the pharmacy is in-network because an out-of-network pharmacy can void the coverage approval. Manufacturer savings programs from Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) can reduce remaining cost-sharing.

  6. 6
    If Denied, Request the Denial Reason in Writing Immediately

    A prior authorization denial is not final. Federal law under the ACA and ERISA requires the insurer to issue a written denial notice with the specific clinical reason and instructions for filing an internal appeal. ACA-regulated and fully insured employer plans generally allow up to 180 days from the denial date to file an internal appeal. ERISA self-funded plans may have different deadlines, so review your plan documents.

What Your Doctor Needs to Submit for Prior Authorization

The prior authorization package must satisfy your insurer's medical necessity criteria in a single submission. Missing one required document is the most common reason GLP-1 prior authorization requests are delayed or denied on first review. Incomplete submissions also forfeit the peer-to-peer review opportunity that most insurers grant only on the initial request cycle.

  • onlineForms icon
    Letter of Medical Necessity

    Your doctor writes a letter stating your diagnosis, current BMI, all qualifying comorbidities, the prescribed drug and dosage and the clinical rationale for this specific drug over alternatives. The letter should explicitly address any formulary criteria your plan publishes, because insurers match the letter against their clinical coverage policy line by line.

  • takingNotes icon
    Documentation of Prior Weight Loss Attempts

    Most plans require evidence that the patient attempted a structured diet or lifestyle modification program before approving a weight loss drug. Your doctor should include records of any supervised diet program, behavioral counseling or previous medication trials, along with the dates and outcomes of each attempt.

  • checkList icon
    Relevant Lab Results and Vitals

    Include recent HbA1c values if type 2 diabetes is the qualifying comorbidity, blood pressure readings if hypertension applies or sleep study results if sleep apnea is documented. Current BMI from a clinical visit within the past 6 months is required on nearly every plan prior authorization form.

  • find icon
    ICD-10 Diagnosis Codes

    The request must include the correct ICD-10 codes for obesity (E66.01 for morbid obesity due to excess calories, E66.09 for other obesity) and any comorbidities. Some insurers also require Z68 BMI codes alongside the obesity diagnosis code and confirm with your doctor's billing staff before submission. Using an incorrect or missing code is a common administrative reason for denial unrelated to clinical eligibility. 

    Note: ICD-10 codes should be verified against the current ICD-10-CM fiscal year release and flagged for clinical review before use.

  • downloadFile icon
    The Specific Drug, Dosage, and NDC Number

    The authorization request must name the exact drug, starting dosage, expected titration schedule and the NDC (National Drug Code) number. Authorizations are drug-specific and dosage-specific. An approval for Wegovy 0.25 mg does not automatically cover Wegovy 1.0 mg after titration.

What to Do If Your Insurance Denies Weight Loss Medication Coverage?

A prior authorization denial for a weight loss drug is common on first submission. CMS internal appeals data shows that a significant share of appeals across all drug categories result in a reversal and weight loss drug appeals have become increasingly successful as plans have updated clinical coverage policies in response to FDA approvals.

The internal appeal is the required first step before any external review option becomes available. Denial rates for ACA claims can be analyzed at the state, insurer and plan levels.

  1. 1
    Request Your Denial Notice and the Clinical Coverage Policy

    After an internal appeal determination, your insurer must issue a written denial notice within three business days under applicable federal and state rules, though timelines vary by state. The notice must name the specific reason the request failed to meet criteria. Also request the insurer's published clinical coverage policy for obesity drug coverage. It lists the exact criteria the plan applies. Every stated reason for denial must be addressed directly in the appeal.

  2. 2
    Have Your Doctor Write a Targeted Appeal Letter

    The appeal letter must rebut each clinical reason in the denial notice, cite peer-reviewed literature supporting the drug's clinical benefit for your specific condition and reference the FDA approval alongside any AHA or Obesity Medicine Association guidelines that support coverage. If a peer-to-peer review was not done on the initial submission, ask your doctor to request one at the same time.

  3. 3
    Submit Your Appeal Within the Plan's Deadline

    File the internal appeal letter, all supporting documentation and any peer-to-peer review request through your insurer's formal appeals process. ACA-regulated plans must allow at least 180 days from the denial date for non-urgent internal appeals. Keep copies of all materials and get a confirmation number or written receipt of submission.

  4. 4
    Escalate to External Review if the Internal Appeal Is Denied

    A denied internal appeal gives you the right under the ACA to request an independent external review by an accredited third-party reviewer. External reviewers issue binding decisions and are not employed by the insurer. ACA-regulated and fully insured employer plan members must file within four months of the internal appeal denial. ERISA self-funded plans may have different external review rights, so check your plan documents.

How to Request a Formulary Exception?

A formulary exception is the correct path when a weight loss drug is not listed on your plan's formulary at all, rather than a prior authorization appeal. A formulary exception requires your doctor to show that every formulary alternative is contraindicated, ineffective or clinically inappropriate for you.

Some plans approve formulary exceptions for GLP-1 drugs when the patient has a documented cardiovascular condition because the SELECT trial showed cardiovascular risk reduction with semaglutide.

insuranceCheck icon
DOES YOUR EMPLOYER PLAN EXCLUDE WEIGHT LOSS DRUGS ENTIRELY?

Some self-funded employer plans explicitly exclude weight loss drugs in their plan documents and this exclusion is legal under ERISA even for FDA-approved medications.

If your employer plan document lists weight loss drugs as an excluded benefit category, neither a prior authorization appeal nor a formulary exception will result in coverage. Your options are the manufacturer savings program, a patient assistance program or switching plans at the next open enrollment period.

What Weight Loss Medication Costs With and Without Insurance Coverage?

With prior authorization approved, your out-of-pocket cost depends on your plan's tier placement for the prescribed drug. Tier 3 or Tier 4 coinsurance typically places the patient share at 30% to 50% of the negotiated drug cost. For Wegovy, which carries a list price of approximately $1,349 per month, 30% coinsurance after approval means roughly $405 per month before any manufacturer assistance is applied. Without approval, the full list price applies at the pharmacy counter. The Prescription drug costs by state and coverage vary and can affect your total annual spend.

Novo Nordisk's NovoCare Patient Assistance Program covers Wegovy at no cost for patients with household income at or below 400% of the federal poverty level. Eli Lilly offers a similar program for Zepbound. Manufacturer savings cards are available to commercially insured patients and can reduce monthly cost-sharing to as low as $25 per month for eligible patients, regardless of tier placement.

Getting Insurance to Cover Weight Loss Medicine: Bottom Line

Most health plans cover FDA-approved weight loss drugs when prior authorization criteria are met. You will need medical necessity documentation from your doctor, including your BMI, qualifying co-morbidities and prior weight loss attempts. If your plan denies coverage, CMS internal appeals data shows that a significant share of appeals across drug categories result in a reversal. If your employer plan excludes these drugs entirely, open enrollment is your best opportunity to switch to a plan with weight loss drug coverage.

Weight Loss Medication Insurance Coverage: FAQ

About Mark Fitzpatrick


Mark Fitzpatrick, Licensed P&C Insurance Expert, MoneyGeek

Mark Fitzpatrick, a licensed Property and Casualty (P&C) Insurance Producer in Connecticut, is MoneyGeek's resident insurance expert. He has spent nearly a decade analyzing the market, first at LendingTree and now at MoneyGeek, where he produces original research on hundreds of carriers and millions of rates across auto, home, renters, health and life insurance.

He covers economics and insurance at MoneyGeek, and his work has been featured in The Washington Post, The New York Times and NPR, among other outlets.

Like all MoneyGeek analysts, he draws on independent cost and consumer experience data. No insurance company partnership influences his recommendations.

Mark holds a B.A. from Boston College and an M.A. in Economics and International Relations from Johns Hopkins University. He started his career in financial risk management at State Street and is also a five-time “Jeopardy!” champion.